Problems of choosing antimicrobial therapy in young children with community-acquired pneumonia

Abstract

Objective: to analyze the prescribed antimicrobial therapy in young children with non-severe community-acquired pneumonia. Materials and methods: a sample of 219 young children with community-acquired pneumonia admitted to the pediatric department of the State Children's Clinical Hospital №17 in Ufa for the period from September 2022 to August 2023 was formed. Results: the clinical and anamnestic characteristics of children with community-acquired pneumonia are described. Analysis of antimicrobial therapy at the outpatient stage revealed in 51,24% of cases its compliance with clinical recommendations. There was a large share of parenteral drugs (73,97%) in the treatment of community-acquired pneumonia in a hospital setting. Preference was given to ceftriaxone (43,38%) due to the convenience of the method of administration. Inhibitor-protected aminopenicillins were prescribed half as often (23,29%). Conclusion: The authors believe that well-planned educational interventions will improve the effectiveness of antimicrobial therapy for community-acquired pneumonia in children.

Keywords

• antimicrobial therapy
• children
• community-acquired pneumonia
• online platforms amrmap and amrbook